Lakeside Life Science was founded in January of 2015, by W. Jeffrey and Paul Allard. We founded Lakeside to bring patients and communities together to advance personalized medicine through the research and development of novel diagnostic tests. We provide the resources for our clients to bring their assays from invention to FDA clearance/approval, while putting the patient's needs first.
W. Jeffrey Allard, Ph.D
Founder and President
Jeff earned his Ph.D from Dartmouth College, in Biochemistry. Since obtaining his Doctorate, Dr. Allard has brought six "new to the world" diagnostic tests through FDA, with +30 FDA clearances and approvals. He has launched sixteen new products. He has authored over 100 scientific papers and abstracts, and he invented, developed, and obtained FDA clearance for the first complexed PSA assay.
VP of Quality & Regulatory Affairs
Gabriela earned her degree in Biochemistry from Virginia Tech (VPI&SU), her MBA from Long Island University, and is a Certified Regulatory Affairs Professional. She has more than 30 years of experience with Medical Devices in both human and veterinary markets. Gabriela manages the regulatory and quality aspects of the company.
Paul J. Allard, RN
Co-Founder and COO
Paul Allard is a Registered Nurse and Co-founder of Lakeside Life Science. Paul saw the need to bring patients back to the foreground of clinical research. He has a proven history of clinical site management as well as a vision to bring academic centers and community centers together to further medical research. Paul manages all day-to-day operations of the company.
M. Craig Miller
Clinical Affairs and Biostatistics
Craig has been contributing to Lakeside Life Science since its inception in 2015. He specializes in clinical study design and statistical analysis plans for all Lakeside protocols, and has developed numerous research and pivotal clinical study protocols. He has over 20 years of experience in the in vitro diagnostics industry. Craig is co-author of over 80 peer-reviewed publications.